EUVIMEDEUVIMED entdecken
Crossref

Evaluating the diagnostic potential of gelsolin in gestational diabetes mellitus: A case–control study

Betül Tokgöz Çakır iD, Gizem Aktemur iD, Gülşan Karabay iD, Zeynep Şeyhanlı iD, Serap Topkara Sucu iD, Ömer Osman Eroğlu iD, Seval Yılmaz Ergani iD, Can Tekin İskender iD

International Journal of Gynecology & Obstetrics · 2025-02 · 168 (2) · 656-662

DOI: 10.1002/ijgo.15872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 21.08.2024. Verfasst von Betül Tokgöz Çakır und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Division of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Diabetes, Gestational, Gelsolin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the association between gestational diabetes mellitus (GDM) and blood levels of gelsolin (an inflammation‐related protein thought to be reduced in type 2 diabetes mellitus) and to determine its role in potential diagnosis and neonatal outcomes.

Methods

This prospective case–control study was conducted at Ankara Etlik City Hospital between November 2023 and February 2024 with 40 pregnant women with GDM and 40 normoglycemic women. Pregnant women aged 18–40 years who were in their 24th to 28th week of pregnancy and had no known chronic disease were included in the present study and it was investigated as to whether there was a significant difference between the two groups in terms of gelsolin levels and neonatal outcome.

Results

Gelsolin level was statistically significantly lower in the GDM group than in the control group ( P = 0.004). In patients with fasting blood glucose

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalGelsolinHumansFemalePregnancyCase-Control StudiesAdultProspective StudiesYoung AdultInfant, NewbornBiomarkersAdolescentBlood GlucosePregnancy OutcomeSensitivity and Specificity

Stichwörter der Autor:innen

fasting blood glucosegelsolingestational diabetes mellitus

Substanzen

GelsolinBiomarkersBlood Glucose

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Division of Perinatology, Ankara Etlik City Hospital, Ankara, Turkey.
  • Department of Obstetrics and Gynecology, Ankara Etlik City Hospital, Ankara, Turkey.

ORCID-Profile: Betül Tokgöz Çakır, Gizem Aktemur, Gülşan Karabay, Zeynep Şeyhanlı, Serap Topkara Sucu, Ömer Osman Eroğlu, Seval Yılmaz Ergani, Can Tekin İskender

Zitieren

APA

Tokgöz Çakır, B., Aktemur, G., Karabay, G., Şeyhanlı, Z., Topkara Sucu, S., Eroğlu, Ö. O., Yılmaz Ergani, S., & İskender, C. T. (2025). Evaluating the diagnostic potential of gelsolin in gestational diabetes mellitus: A case–control study. International Journal of Gynecology & Obstetrics, 168(2), 656-662. https://doi.org/10.1002/ijgo.15872

Vancouver

Tokgöz Çakır B, Aktemur G, Karabay G, Şeyhanlı Z, Topkara Sucu S, Eroğlu ÖO, et al. Evaluating the diagnostic potential of gelsolin in gestational diabetes mellitus: A case–control study. International Journal of Gynecology & Obstetrics. 2025;168(2):656-662. doi:10.1002/ijgo.15872

BibTeX
@article{Tokgzakr2025,
  author = {Tokgöz Çakır, Betül and Aktemur, Gizem and Karabay, Gülşan and Şeyhanlı, Zeynep and Topkara Sucu, Serap and Eroğlu, Ömer Osman and Yılmaz Ergani, Seval and İskender, Can Tekin},
  title = {Evaluating the diagnostic potential of gelsolin in gestational diabetes mellitus: A case–control study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  volume = {168},
  number = {2},
  pages = {656--662},
  doi = {10.1002/ijgo.15872}
}
Kostenlos starten →